Further, peptides are attractive strategies for cancer treatment due to their binding to specific receptors, such as the receptors in the programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) signaling pathway. The gene discussed is PDCD1; the disease is cancer.